Skip to main content


Featured Article
“Homeless patients with hypertension and/or type 2 diabetes who had at least one visit with a pharmacist showed some improved health outcomes,” researchers wrote.
Patients with venous thromboembolism (VTE) who take statins may have a significantly lower risk of recurrent VTE, according to a new study.


Mark Munger, PharmD, discusses why the search for improving outcomes in HFrEF using newer anti-coagulants continues.
Mark Munger, PharmD, discusses recent study findings, which show that ranolazine increases the adverse effect profile of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, raising concern for patient safety.
Mahmoud Barbarawi, MD, department of internal medicine at the Hurley Medical Center (Flint, Michigan), shares insights from his recent study and highlights gaps of knowledge that still exist between vitamin D supplementation and cardiovascular…
Kiersten Combs, vice president of US Cardiovascular & Metabolic Disease, and Jim McDermott, vice president of US Medical Affairs and Metabolism, both at AstraZeneca, highlight how the use of Farxiga and other SGLT2 inhibitors impact payers and…
Back to Top